Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Age-Adjusted Associations Between Comorbidity and Outcomes of COVID-19: A Review of the Evidence From the Early Stages of the Pandemic
Kate Mason, Gillian Maudsley, Philip McHale, et al.
Frontiers in Public Health (2021) Vol. 9
Open Access | Times Cited: 39

Showing 1-25 of 39 citing articles:

Characteristics and predictors of hospitalization and death in the first 11 122 cases with a positive RT-PCR test for SARS-CoV-2 in Denmark: a nationwide cohort
Mette Reilev, Kasper Bruun Kristensen, Anton Pottegård, et al.
International Journal of Epidemiology (2020) Vol. 49, Iss. 5, pp. 1468-1481
Open Access | Times Cited: 264
How does vulnerability to COVID-19 vary between communities in England? Developing a Small Area Vulnerability Index (SAVI)
Konstantinos Daras, Alexandros Alexiou, Tanith C. Rose, et al.
Journal of Epidemiology & Community Health (2021) Vol. 75, Iss. 8, pp. 729-734
Open Access | Times Cited: 80
Autoantibodies in COVID-19: implications for disease severity and clinical outcomes
Yannick Galipeau, Curtis Cooper, Marc‐André Langlois
Frontiers in Immunology (2025) Vol. 15
Open Access | Times Cited: 1
Cost-Effectiveness Analysis of Molnupiravir Versus Best Supportive Care for the Treatment of Outpatient COVID-19 in Adults in the US
Hardik Goswami, Adnan Alsumali, Yiling Jiang, et al.
PharmacoEconomics (2022) Vol. 40, Iss. 7, pp. 699-714
Open Access | Times Cited: 29
High Mortality of COVID-19 Early after Allogeneic Stem Cell Transplantation: A Retrospective Multicenter Analysis on Behalf of the German Cooperative Transplant Study Group
Judith Schaffrath, Christina Brummer, Daniel Wolff, et al.
Transplantation and Cellular Therapy (2022) Vol. 28, Iss. 6, pp. 337.e1-337.e10
Open Access | Times Cited: 23
Machine learning and comorbidity network analysis for hospitalized patients with COVID-19 in a city in Southern Brazil
Hemanoel Passarelli‐Araujo, Hisrael Passarelli-Araujo, Mariana Ragassi Urbano, et al.
Smart Health (2022) Vol. 26, pp. 100323-100323
Open Access | Times Cited: 13
Public health impact of UK COVID-19 booster vaccination programs during Omicron predominance
Diana Mendes, Ruth Chapman, Elena Aruffo, et al.
Expert Review of Vaccines (2022) Vol. 22, Iss. 1, pp. 90-103
Open Access | Times Cited: 11
The natural killer cell‐associated rs9916629‐C allele is a novel genetic risk factor for fatal COVID‐19
Hannes Vietzen, Philippe L. Furlano, Marianna Traugott, et al.
Journal of Medical Virology (2022) Vol. 95, Iss. 1
Open Access | Times Cited: 8
Age and Comorbidity Burden of Patients Critically Ill with COVID-19 Affect Both Access to and Outcome of Ventilation Therapy in Intensive Care Units
Marie Louise de Hesselle, Stefan Borgmann, Siegbert Rieg, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 7, pp. 2469-2469
Open Access | Times Cited: 4
Blood Biomarkers from the Emergency Department Disclose Severe Omicron COVID-19-Associated Outcomes
Fiorenza Pennacchia, Eqrem Rusi, Wael Abu Ruqa, et al.
Microorganisms (2023) Vol. 11, Iss. 4, pp. 925-925
Open Access | Times Cited: 4
Modeling the potential public health and economic impact of different COVID-19 booster dose vaccination strategies with an adapted vaccine in the United Kingdom
Cale Harrison, Rebecca Butfield, Benjamin Yarnoff, et al.
Expert Review of Vaccines (2024) Vol. 23, Iss. 1, pp. 730-739
Open Access | Times Cited: 1
Asymptomatic COVID‐19 and ST‐elevation myocardial infarction in young adults: lessons learned from two similar cases
Hamayak Sisakian, S. Kosmacheva E. Martirosyan, S. V. Shekoyan, et al.
ESC Heart Failure (2021) Vol. 9, Iss. 1, pp. 775-781
Open Access | Times Cited: 10
COVID-19 Outcomes and Genomic Characterization of SARS-CoV-2 Isolated From Veterans in New England States: Retrospective Analysis
Megan Lee, Ya Haddy Sallah, Mary E. Petrone, et al.
JMIRx Med (2021) Vol. 2, Iss. 4, pp. e31503-e31503
Open Access | Times Cited: 8
Public health impact of booster vaccination against COVID-19 in the UK during Delta variant dominance in autumn 2021
Diana Mendes, Ruth Chapman, Peter Gal, et al.
Journal of Medical Economics (2022) Vol. 25, Iss. 1, pp. 1039-1050
Open Access | Times Cited: 6
Exploration of the psychometric properties of the novel General Medication Adherence Scale (GMAS) for chronic illness patients
Xiaoxuan Meng, Siyuan Li, Wenting Shen, et al.
Current Medical Research and Opinion (2023) Vol. 39, Iss. 5, pp. 671-679
Closed Access | Times Cited: 3
The Incidence Proportion of SARS-CoV-2 Infections and the Percentage of Deaths among Infected Healthcare Workers in Poland
Marek Wojczyk, Ewa Niewiadomska, Małgorzata Kowalska
Journal of Clinical Medicine (2023) Vol. 12, Iss. 11, pp. 3714-3714
Open Access | Times Cited: 3
Cross-sectional Characterization of SARS-CoV-2 Antibody Levels and Decay Rates Following Infection of Unvaccinated Elderly Individuals
Marilyn Whelan, Yannick Galipeau, Nicole White-Al Habeeb, et al.
Open Forum Infectious Diseases (2023) Vol. 10, Iss. 8
Open Access | Times Cited: 3
Risk factors for COVID-19 infection and disease severity in Nigeria: a case-control study
Rowland Utulu, IkeOluwapo O. Ajayi, Segun Bello, et al.
Pan African Medical Journal (2022) Vol. 41
Open Access | Times Cited: 5
Prevalence of SARS-CoV-2 Infections and the Percentage of Deaths Among Infected Healthcare Workers in Poland
Marek Wojczyk, Ewa Niewiadomska, Małgorzata Kowalska
(2023)
Open Access | Times Cited: 2
Modeling mechanisms underlying differential inflammatory responses to COVID-19 in type 2 diabetes using a patient-derived microphysiological organ-on-a-chip system
Vinny Negi, Dillon Gavlock, Mark T. Miedel, et al.
Lab on a Chip (2023) Vol. 23, Iss. 20, pp. 4514-4527
Closed Access | Times Cited: 2
COVID-19 orphans—Global patterns associated with the hidden pandemic
Callum Lowe, Leli Rachmawati, Alice Richardson, et al.
PLOS Global Public Health (2022) Vol. 2, Iss. 8, pp. e0000317-e0000317
Open Access | Times Cited: 4
Prevention of Cardiovascular Burden in COVID-19 Patients Suffering from Familial Hypercholesterolemia: A Global Challenge
Alpo Vuorio, Petri T. Kovanen, Raúl D. Santos, et al.
Cardiology and Therapy (2021) Vol. 11, Iss. 1, pp. 1-7
Open Access | Times Cited: 5
Changes in Inflammatory Markers after Administration of Tocilizumab in COVID-19: A Single-Center Retrospective Study
Anna Olewicz‐Gawlik, Barbara Ginter-Matuszewska, Mikołaj Kamiński, et al.
Journal of Clinical Medicine (2021) Vol. 11, Iss. 1, pp. 107-107
Open Access | Times Cited: 5
Genetic Control of Human Infection with SARS-CoV-2
А. Н. Кучер, Н. П. Бабушкина, Aleksei A. Sleptcov, et al.
Russian Journal of Genetics (2021) Vol. 57, Iss. 6, pp. 627-641
Open Access | Times Cited: 4
Comparison of the First and Second Wave of Infections by SARS-CoV-2: A Retrospective and Longitudinal Study From a Primary Health Care Center in Santiago of Chile
Claudio Acuña‐Castillo, Ailén Inostroza-Molina, Sergio A. Castro, et al.
Frontiers in Public Health (2022) Vol. 10
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top